Alertix

Saudi Arabia
Al Fuwayliq, Al-Qassim Region, Saudi Arabia, 392 30

Company profile

Alertix company profile

Alertix Veterinary Diagnostics AB was founded in 2017. The goal of the company is to commercialize discoveries from Swedish veterinary medical biotech research. In particular concerning a new, powerful method for measuring the presence of the enzyme thymidine kinase 1 (TK1) in serum of animals important in veterinary medicine. TK1 is a biomarker for tumor growth and cell turnover. The substance has been detected in serum of patients even before they show clinical symptoms. This means that the assay can be a valuable tool for early diagnosis of cancer diseases. Unlike previously established methods for detecting TK1 the Alertix method is an immunochemical routine method, which can also successfully detect serum TK1 in patients with solid tumors.

Business identity

Contact email
[email protected]
Phone number
559095-7477
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2017-01-01, Year

Headquarters

Postal code
392 30
Country code
SA
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$407,935
Last funding
Series Unknown / 2020-09-02
Last equity funding
Series Unknown
Investors
2
Lead investors
1
Founders
1

Founders and investors

Founders

Bengt Åstrand

Lead investors

Almi Invest

Investors

Almi InvestSLU Holding